Figure 2.
Recurrence-free survival and C2GnT-1 expression in stage I disease. In patients with stage I seminoma and NSGCT, C2GnT-1-positive cases had a significantly higher risk for recurrence.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.